Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V L Mar

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinantW Cieplak, W N Burnette, V L Mar, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Developments toward a recombinant pertussis vaccineW N Burnette, D W Whiteley, V L Mar, et al.
Infection and Immunity|November 1, 1991
Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activityW N Burnette, V L Mar, B W Platler, et al.
Infection and Immunity|August 1, 1994
Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogsC C Häse, L S Thai, M Boesman-Finkelstein, et al.
Developments in Biological Standardization|January 11, 1991
The molecular engineering of pertussis toxoidW N Burnette, V L Mar, T D Bartley, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinantW Cieplak, W N Burnette, V L Mar, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Developments toward a recombinant pertussis vaccineW N Burnette, D W Whiteley, V L Mar, et al.
Infection and Immunity|November 1, 1991
Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activityW N Burnette, V L Mar, B W Platler, et al.
Infection and Immunity|August 1, 1994
Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogsC C Häse, L S Thai, M Boesman-Finkelstein, et al.
Developments in Biological Standardization|January 11, 1991
The molecular engineering of pertussis toxoidW N Burnette, V L Mar, T D Bartley, et al.
Pageof 2